What is the appropriate dose of Dextrose 50% (D50) 50 ml intravenous push based on the patient's capillary blood glucose level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

D50 Dosing Based on Capillary Blood Glucose

For hypoglycemic patients with altered mental status or inability to take oral glucose, administer 10-25 grams of IV dextrose (20-50 mL of D50), with the standard initial dose being 25 grams (50 mL of D50) for adults. 1

Dosing Algorithm by Clinical Presentation

Conscious Patients Who Can Swallow

  • Do not use IV dextrose - these patients should receive oral glucose instead 2, 3
  • Give 15-20 grams of oral glucose tablets or equivalent dietary sugars
  • Activate EMS if no improvement within 10 minutes 2

Unconscious or Unable to Swallow Patients

Initial IV Dextrose Dose:

  • Standard approach: 25 grams (50 mL of D50) administered slowly IV 1
  • Alternative approach: Start with 10 grams (20 mL of D50) and titrate in 5-gram increments 4, 5

The CBG level itself does not dictate the exact dose - the key determinant is the patient's mental status and ability to protect their airway. The FDA label specifies 10-25 grams as adequate for insulin-induced hypoglycemia, with repeated doses and supportive treatment required in severe cases 1.

Evidence-Based Considerations

Lower Concentration Alternatives

Recent evidence suggests 10% dextrose (D10) may be preferable to D50 when available 5, 6:

  • Achieves same symptom resolution (95.9% vs 88.8%)
  • Takes approximately 4 minutes longer to work (8 minutes vs 4 minutes)
  • Results in lower post-treatment glucose (6.2 mmol/L vs 8.5-9.4 mmol/L)
  • Fewer adverse events (0% vs 4.2%)
  • Requires more frequent repeat dosing (19.5% vs 8.1%)

Rebound Hyperglycemia Risk

D50 commonly causes rebound hyperglycemia within 5 minutes 7:

  • Mean post-treatment glucose: 12.2 mmol/L (220 mg/dL)
  • Maximum observed: 22.6 mmol/L (407 mg/dL)
  • More common in non-diabetics (73.3%) than diabetics (56.3%)

Titration Strategy

If using D50, consider titrating in 5-gram (10 mL) aliquots rather than giving the full 25-gram ampule 4, 5:

  • Median effective dose is only 10-15 grams
  • Reduces post-treatment hyperglycemia
  • Allows for more controlled glucose correction
  • Monitor response between doses

Administration Technique

  • Administer slowly - maximum safe infusion rate is 0.5 g/kg/hour 1
  • For a 70 kg patient, this translates to approximately 35 grams/hour maximum
  • The 25-gram bolus should be given over at least 1-2 minutes
  • Obtain blood glucose before administration when possible, but do not delay treatment in true emergencies 1

Common Pitfalls

  1. Giving full 50 mL ampule reflexively - this often overshoots, causing rebound hyperglycemia 7
  2. Using IV dextrose in conscious patients - oral glucose is safer and equally effective 2, 3
  3. Administering too rapidly - increases risk of extravasation injury and rebound hyperglycemia
  4. Not reassessing after initial dose - 5.7% of patients require a second dose 7
  5. Forgetting follow-up care - diabetic patients may need continuous dextrose infusion or feeding to prevent recurrence 7

Post-Administration Monitoring

  • Recheck glucose at 5-10 minute intervals
  • Assess mental status improvement (target GCS 15)
  • Median time to full recovery: 6-8 minutes 4, 5
  • Ensure patient begins oral intake or receives maintenance dextrose infusion to prevent recurrence

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.